Molecule of the month. Tecovirimat.
D000284:Administration, Oral; D000818:Animals; D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D054833:Isoindoles / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D018155:Orthopoxvirus / Q000187:drug effects; D011213:Poxviridae Infections / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012899:Smallpox / Q000188:drug therapy; D010797:Phthalimides
D000998:Antiviral Agents; D001549:Benzamides; D054833:Isoindoles; C505045:tecovirimat; D010797:Phthalimides